NCT02225405
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Stage IIIA Non-Small Cell Lung Cancer AJCC v7
Explore clinical trials studying Stage IIIA Non-Small Cell Lung Cancer AJCC v7. Study availability and eligibility vary by location and protocol.
6 public trials
0 recruiting studies
Stage IIIA Non-Small Cell Lung Cancer AJCC v7 trial results
NCT03229278
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +73 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
NCT01727076
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +47 more
- Locations
-
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
- Seattle Cancer Care Alliance Seattle, Washington, United States
Active, Not Recruiting
Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer
NCT01993810
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- University of Florida Health Science Center - Jacksonville Jacksonville, Florida, United States
- Northwestern Medicine Cancer Center Warrenville Warrenville, Illinois, United States
- Maryland Proton Treatment Center Baltimore, Maryland, United States
- University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States
Active, Not Recruiting
Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-IIIB Non-small Cell Lung Cancer
NCT01629498
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +13 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992
- Conditions
- ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States